Provided by Tiger Trade Technology Pte. Ltd.

GSK plc ADRhedged

66.97
-0.3971-0.59%
Post-market: 66.87-0.1033-0.15%16:10 EDT
Volume:322
Turnover:21.54K
Market Cap:669.80K
PE:- -
High:66.97
Open:66.92
Low:66.87
Close:67.37
52wk High:85.03
52wk Low:60.91
Shares:10.00K
Float Shares:10.00K
Volume Ratio:1.48
T/O Rate:3.22%
Dividend:2.08
Dividend Rate:3.10%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Top 20 US Stocks by Trading Volume on June 10: Nuvalent Soars Over 39% on GSK Acquisition Deal

Deep News
·
Jun 10

Micron, Marvell, Super Micro, Coherent, Smucker, and More Stocks That Explain Today's Market -- Barrons.com

Dow Jones
·
Jun 10

Nuvalent Acquisition Fairly Valued, Competing Bid Seen as Unlikely, Wedbush Says

MT Newswires Live
·
Jun 10

GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares

cityam
·
Jun 10

GSK Director Hal Barron Takes Governance Role at Quantinuum

TIPRANKS
·
Jun 10

Sector Update: Healthcare

MT Newswires Live
·
Jun 10

Midday Fly By: OpenAI files for IPO, GSK to acquire Nuvalent

TIPRANKS
·
Jun 10

Top Midday Stories: GSK to Acquire Nuvalent for $10.6 Billion in Cash; Apple Introduces Siri AI, But EU Launch to be Delayed

MT Newswires Live
·
Jun 09

Nuvalent Stock Jumps 39% on Surprise GSK Cancer-Drug Deal -- Barrons.com

Dow Jones
·
Jun 09

GSK's Nuvalent Deal Makes Strategic Sense -- Market Talk

Dow Jones
·
Jun 09

Video: Nuvalent jumps after GSK’s $10.6B takeover deal

TIPRANKS
·
Jun 09

Nuvalent Shares Soar Following GSK's Acquisition Announcement

Deep News
·
Jun 09

GSK's $10.6 Billion Acquisition of Nuvalent Bolsters Its Oncology Pipeline with Targeted Lung Cancer Drugs

Deep News
·
Jun 09

Nuvalent to Be Acquired by GSK in Cash Deal

TIPRANKS
·
Jun 09

How a former lawyer is beating the stock market with these 11 picks

Dow Jones
·
Jun 09

UBS Remains a Hold on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 09

Nuvalent Shares Leap Premarket on Takeover by GSK

Dow Jones
·
Jun 09

GlaxoSmithKline (GSK) Gets a Sell from Barclays

TIPRANKS
·
Jun 09

GlaxoSmithKline Announces $10.6 Billion Acquisition of US Biopharma Firm Nuvalent

Deep News
·
Jun 09

GSK's $10.6 Billion Nuvalent Deal Raises Eyebrows -- Market Talk

Dow Jones
·
Jun 09